Hand, foot and mouth disease as an important public health challenge: clinical manifestation, diagnosis and treatment, literature review
Streszczenie
Introduction and objective: The ailment commonly referred to as Boston exanthem disease is also known as hand, foot and mouth disease (HFMD). It is an infectious viral ailment usually of mild nature, triggered by enteroviruses and the coxsackie virus. Typical symptoms of HFMD include elevated temperature, fatigue, reduced appetite, abdominal and throat discomfort, painful mouth sores, and skin lesions. The incubation period ranges from 3–6 days, with symptoms persisting for 7–10 days. Today, the established diagnostic criteria for HFMD rely mainly on clinical symptoms and patient history. Most HFMD patients receive outpatient care with supportive measures alone, while isolation is recommended to reduce disease transmission. Generally, HFMD is mild and does not result in permanent damage. Dehydration stands as the primary complication, while the most severe consequences are associated with the central nervous system (CNS). This review was aimed at exploring the recent literature on HFMD, focusing on its epidemiology, aetiological factors, and novel strategies for its prevention and management.
Material and methods: The authors’ main goal was to summarise current scientific reports on the researched topic based on databases such as PubMed, Google Scholar, and taking into account their own materials (photos).
Conclusions: The prevalence of this illness is rising. It is crucial to highlight its highly contagious nature, making it capable of rapid and widespread transmission. Understanding Boston exanthem disease and encompassing both typical and atypical symptoms is essential for accurate diagnosis and effective treatment protocols. This article discusses the most recent literature concerning HFMD, with a special focus on epidemiology, its defining traits and causative factors, and emerging strategies for its prevention and management.
Słowa kluczowe: handfoot and mouth diseaseHFMDBoston exanthem diseaseinfectious diseases
Referencje
- Saguil A, Kane SF, Lauters R, Mercado MG. Hand-Foot-and-Mouth Disease: Rapid Evidence Review. 2019. www.aafp.org/afp (06.05.2024).
- Repass GL, Palmer WC, Stancampiano FF. Hand, foot, and mouth disease: identifying and managing an acute viral syndrome. Cleve Clin J Med. 2014; 81(9): 537–543.
- Ślebioda Z, Dorocka-Bobkowska B. Hand, foot and mouth disease as an emerging public health problem: Case report of familial child-to-adult transmission. Dent Med Probl. 2018; 55(1): 99–104.
- Zhang X, Zhang Y, Li H, et al. Hand-Foot-and-Mouth Disease-Associated Enterovirus and the Development of Multivalent HFMD Vaccines. Int J Mol Sci. 2022; 24(1).
- Ventarola D, Bordone L, Silverberg N. Update on hand-foot-and-mouth disease. Clin Dermatol. 2015; 33(3): 340–346.
- Nayak G, Bhuyan SK, Bhuyan R, et al. Global emergence of Enterovirus 71: a systematic review. Beni Suef Univ J Basic Appl Sci. 2022; 11(1): 78.
- Nassef C, Ziemer C, Morrell DS. Hand-foot-and-mouth disease: a new look at a classic viral rash. Curr Opin Pediatr. 2015; 27(4): 486–491.
- Esposito S, Principi N. Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention. Eur J Clin Microbiol Infect Dis. 2018; 37(3): 391–398.
- Aswathyraj S, Arunkumar G, Alidjinou EK, et al. Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy. Med Microbiol Immunol. 2016; 205(5): 397–407.
- Hubiche T, Schuffenecker I, Boralevi F, et al. Clinical Research Group of the French Society of Pediatric Dermatology Groupe de Recherche Clinique de la Société Française de Dermatologie Pédiatrique. Dermatological spectrum of hand, foot and mouth disease from classical to generalized exanthema. Pediatr Infect Dis J. 2014; 33(4): e92–e98.
- Flett K, Youngster I, Huang J, et al. Hand, foot, and mouth disease caused by coxsackievirus a6. Emerg Infect Dis. 2012; 18(10): 1702–1704.
- Mathes EF, Oza V, Frieden IJ, et al. "Eczema coxsackium" and unusual cutaneous findings in an enterovirus outbreak. Pediatrics. 2013; 132(1): e149–e157.
- Sinclair C, Gaunt E, Simmonds P, et al. Atypical hand, foot, and mouth disease associated with coxsackievirus A6 infection, Edinburgh, United Kingdom, January to February 2014. Euro Surveill. 2014; 19(12): 20745.
- Zhu P, Ji W, Li D, et al. Current status of hand-foot-and-mouth disease. J Biomed Sci. 2023; 30(1): 15.
- Li XW, Ni X, Qian SY, et al. Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition). World J Pediatr. 2018; 14(5): 437–447.
- Lin JY, Kung YA, Shih SR. Antivirals and vaccines for Enterovirus A71. J Biomed Sci. 2019; 26(1): 65.
- Lin H, Huang L, Zhou J, et al. Efficacy and safety of interferon-α2b spray in the treatment of hand, foot, and mouth disease: a multicenter, randomized, double-blind trial. Arch Virol. 2016; 161(11): 3073–3080.
- Li R, Liu L, Mo Z, et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014; 370(9): 829–837.
- Solomon T, Lewthwaite P, Perera D, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010; 10(11): 778–790.
- Zhang Q, MacDonald NE, Smith JC, et al. Severe enterovirus type 71 nervous system infections in children in the Shanghai region of China: clinical manifestations and implications for prevention and care. Pediatr Infect Dis J. 2014; 33(5): 482–487.
- Huang Y, Zhou Y, Lu H, et al. Characterization of severe hand, foot, and mouth disease in Shenzhen, China, 2009-2013. J Med Virol. 2015; 87(9): 1471–1479.
- Xing W, Liao Q, Viboud C, et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis. 2014; 14(4): 308–318.
- Koh WM, Bogich T, Siegel K, et al. The Epidemiology of Hand, Foot and Mouth Disease in Asia: A Systematic Review and Analysis. Pediatr Infect Dis J. 2016; 35(10): e285–e300.
- Davia JL, Bel PH, Ninet VZ, et al. Onychomadesis outbreak in Valencia, Spain associated with hand, foot, and mouth disease caused by enteroviruses. Pediatr Dermatol. 2011; 28(1): 1–5.